SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583648-18-000032
Filing Date
2018-05-10
Accepted
2018-05-10 16:19:26
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pirs3-31x201810xq.htm 10-Q 564369
2 EXHIBIT 10.1 a18050320181q10qexhibit101.htm EX-10.1 1182314
3 EXHIBIT 10.2 a18050320181q10qexhibit102.htm EX-10.2 240008
4 EXHIBIT 31.1 exhibit311.htm EX-31.1 9790
5 EXHIBIT 31.2 exhibit312.htm EX-31.2 9609
6 EXHIBIT 32.1 exhibit321.htm EX-32.1 5671
7 EXHIBIT 32.2 exhibit322.htm EX-32.2 5543
  Complete submission text file 0001583648-18-000032.txt   4359726

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pirs-20180331.xml EX-101.INS 538723
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20180331.xsd EX-101.SCH 26720
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20180331_cal.xml EX-101.CAL 48678
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20180331_def.xml EX-101.DEF 90447
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20180331_lab.xml EX-101.LAB 321679
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20180331_pre.xml EX-101.PRE 181826
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 18822787
SIC: 8731 Services-Commercial Physical & Biological Research